Update: The Global Klebsiella Testing Market Is Expected To Grow At A CAGR Of 7.1% During The Forecast Period.| Data By Contrive Datum Insights Pvt Ltd.
May 12, 2023 12:44 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, May 12, 2023 (GLOBE NEWSWIRE) -- The Global Klebsiella Testing Market Is Expected To Grow At A CAGR Of 7.1% During The Forecast Period. Klebsiella infection is an infectious disease...
The Global Klebsiella Testing Market Is Expected To Grow At A CAGR Of 7.1% During The Forecast Period.| Data By Contrive Datum Insights Pvt Ltd.
May 08, 2023 13:56 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, May 08, 2023 (GLOBE NEWSWIRE) -- The Global Klebsiella Testing Market Is Expected To Grow At A CAGR Of 7.1% During The Forecast Period. Klebsiella infection is an infectious disease...
Medical Writing Landscape Advancement Summit Provides Unique Learning Opportunities to Improve Content Optimization
February 17, 2021 09:35 ET
|
Lincoln Health Network
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- via BioMedWire -- Lincoln Health Network, a leading conference production company focused on being the go-to source for thought leadership within the...
Clinical Document World Brings Thought Leaders, Innovative Approach to TMF, Inspection Readiness, Document Management, and Clinical Professionals
August 28, 2020 09:35 ET
|
Lincoln Health Network
NEW YORK, Aug. 28, 2020 (GLOBE NEWSWIRE) -- via BioMedWire -- For clinical quality professionals seeking to improve processes through strategic improvements and partnerships, an exciting opportunity...
FWD Pharma Conference 2020 Provides Critical Digital Strategies to Biotech, Life Science Sectors
August 12, 2020 09:35 ET
|
Lincoln Health Network
NEW YORK, Aug. 12, 2020 (GLOBE NEWSWIRE) -- via BioMedWire -- There’s an exciting buildup underway for the 2nd annual FWD Pharma Conference, slated to be held Aug. 31-Sept. 1, 2020. With a...
BrainStorm Issues 2019 Letter to Shareholders
December 18, 2019 05:00 ET
|
BrainStorm Cell Therapeutics Inc.
NEW YORK, Dec. 18, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapeutics for neurodegenerative diseases, today issued a Letter to...
San Antonio to Host 2014 World Stem Cell Summit
September 18, 2013 17:04 ET
|
Genetics Policy Institute
SAN ANTONIO, Texas, Sept. 18, 2013 (GLOBE NEWSWIRE) -- Genetics Policy Institute (GPI), the producer of the annual World Stem Cell Summit, is announcing tonight at BioMed SA's 8th Annual Julio Palmaz...